Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
biologics
Brought to you by:
Biotech
Pfizer, BioNTech combo mRNA shot latest to lose to flu strain B
Pfizer and BioNTech have run up against the same problem as their peers—neutralizing influenza strain B.
James Waldron
Aug 16, 2024 8:25am
Turnstone narrows cell therapy focus to 'high unmet need' tumors
Aug 15, 2024 7:46am
Free-floating bacterial gene challenges biology's cardinal rules
Aug 14, 2024 10:31am
BioNTech, Regeneron rack up response rate win for cancer vaccine
Jul 30, 2024 6:45am
Pfizer gene therapy reduces bleeds in ph. 3 hemophilia A trial
Jul 24, 2024 8:44am
Lexeo links gene therapy to improvements in rare heart disease
Jul 15, 2024 9:46am